Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Matsubara, T.
Right arrow Articles by Nakagawa, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Matsubara, T.
Right arrow Articles by Nakagawa, A.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Esophageal Cancer
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?
Journal of Clinical Oncology, Vol 21, Issue 23 (December), 2003: 4336-4341
© 2003 American Society for Clinical Oncology

Risk of Second Primary Malignancy After Esophagectomy for Squamous Cell Carcinoma of the Thoracic Esophagus

Toshiki Matsubara, Kazuhiko Yamada, Aya Nakagawa

From the Department of Surgery, Cancer Institute Hospital, Tokyo, Japan.

Address reprint requests to Toshiki Matsubara, MD, PhD, 1-12-7 Kohinata, Bunkyou-Ku, Tokyo 112-0006, Japan; e-mail: matsu-bara{at}umin.ac.jp.

Purpose: To assess the risk of subsequent malignancies after esophagectomy for squamous cell carcinoma of the thoracic esophagus for the establishment of an adequate follow-up program.

Patients and Methods: We statistically analyzed clinical factors in 114 cases of second malignancy after esophagectomy that developed in 94 of 679 patients who underwent curative resection. The cancer incidence rates in the general population estimated by the Research Group for Population-Based Cancer Registration in Japan were used as standards for comparison.

Results: The 10-year cumulative risk of second malignancy was 34.5%, and the overall relative risk (RR) was 2.98 (95% CI, 2.41 to 3.65). The risk of head and neck cancer was markedly elevated (RR, 34.9; 95% CI, 24.3 to 48.6), followed by the risks of lung cancer (RR, 3.24; 95% CI, 1.89 to 5.19) and stomach cancer (RR, 2.00; 95% CI, 1.17 to 3.21). Multifactor analysis demonstrated that independent factors affecting the risk of subsequent malignancies were presence of other malignancies detected before esophagectomy and any of the following factors: masculine sex, alcohol consumption, and smoking. The 5-year survival rate after detection of subsequent malignancy was 45%. The outcome in patients with subsequent head and neck cancer was significantly less favorable as a result of difficulty in early detection.

Conclusion: Patients had a remarkably high risk of subsequent cancer of the upper aerodigestive tract after esophagectomy, in particular, head and neck cancer. Minute postoperative surveillance is strongly recommended, especially in patients with a history of malignancies before esophagectomy. Early detection of second malignancies allowed less invasive treatment with favorable outcome.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Ann OncolHome page
E. Bollschweiler, R. Metzger, U. Drebber, S. Baldus, D. Vallbohmer, M. Kocher, and A. H. Holscher
Histological type of esophageal cancer might affect response to neo-adjuvant radiochemotherapy and subsequent prognosis
Ann. Onc., February 1, 2009; 20(2): 231 - 238.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
S.-C. Chuang, M. Hashibe, G. Scelo, D. H. Brewster, E. Pukkala, S. Friis, E. Tracey, E. Weiderpass, K. Hemminki, S. Tamaro, et al.
Risk of Second Primary Cancer among Esophageal Cancer Patients: a Pooled Analysis of 13 Cancer Registries
Cancer Epidemiol. Biomarkers Prev., June 1, 2008; 17(6): 1543 - 1549.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
S. Min Park, M. Kyung Lim, K. Won Jung, S. Ae Shin, K.-Y. Yoo, Y. Ho Yun, and B. Yul Huh
Prediagnosis Smoking, Obesity, Insulin Resistance, and Second Primary Cancer Risk in Male Cancer Survivors: National Health Insurance Corporation Study
J. Clin. Oncol., October 20, 2007; 25(30): 4835 - 4843.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M. Muto, M. Takahashi, A. Ohtsu, S. Ebihara, S. Yoshida, and H. Esumi
Risk of multiple squamous cell carcinomas both in the esophagus and the head and neck region
Carcinogenesis, May 1, 2005; 26(5): 1008 - 1012.
[Abstract] [Full Text] [PDF]


Home page
Jpn J Clin OncolHome page
Y. Tuoheti, K. Okada, T. Osanai, J. Nishida, S. Ehara, M. Hashimoto, and E. Itoi
Skeletal Muscle Metastases of Carcinoma: a Clinicopathological Study of 12 cases
Jpn. J. Clin. Oncol., April 1, 2004; 34(4): 210 - 214.
[Abstract] [Full Text] [PDF]



About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 PDA Services

Copyright © 2003 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online